Biosimilar infliximab versus originator in Crohn’s disease anti-TNF-α naïve and non-naïve patients

Biosimilar infliximab versus originator in Crohn’s disease anti-TNF-α naïve and non-naïve patients

Bibliographic Details
Main Authors: Magdalena Kaniewska, Mariusz Rosołowski, Andrzej Moniuszko, Grazyna Rydzewska
Format: Article
Language:English
Published: Termedia Publishing House 2020-11-01
Series:Gastroenterology Review
Subjects:
inflammatory bowel disease
crohn’s disease
biological treatment
biosimilar
anti-tnf-α naïve
infliximab.
Online Access:https://www.termedia.pl/Biosimilar-infliximab-versus-originator-in-Crohn-s-r-ndisease-anti-TNF-naive-and-non-naive-patients,41,42377,1,1.html

Internet

https://www.termedia.pl/Biosimilar-infliximab-versus-originator-in-Crohn-s-r-ndisease-anti-TNF-naive-and-non-naive-patients,41,42377,1,1.html

Similar Items